UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genome-wide association study and polygenic risk score analysis of esketamine treatment response

Scientific reports, 2020-07, Vol.10 (1), p.12649-12649, Article 12649

2020

Volltextzugriff (PDF)

Risk Factors for Interstitial Cystitis in the General Population and in Individuals With Depression

International Neurourology Journal, 2019, 23(1), , pp.40-45

2019

Volltextzugriff (PDF)

Autism: Comorbidities and Treatment Patterns in the Real World, a Retrospective Cohort Study Among Children, Adolescents and Adults Newly Diagnosed with Autism

Journal of autism and developmental disorders, 2022-10, Vol.52 (10), p.4311-4320

2022

Volltextzugriff (PDF)

Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3

The American journal of geriatric psychiatry, 2020-02, Vol.28 (2), p.121-141

2020

Volltextzugriff (PDF)

First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18

Journal of pain research, 2019-01, Vol.12, p.1925-1936

2019

Volltextzugriff (PDF)

6.11 Clinician and Parent Reporting of Autism Spectrum Disorder Behaviors: Development of a Clinician Version of the Autism Behavior Inventory

Journal of the American Academy of Child and Adolescent Psychiatry, 2021-10, Vol.60 (10), p.S161-S161

2021

Volltextzugriff (PDF)

Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study

The American journal of geriatric psychiatry, 2022-05, Vol.30 (5), p.541-556

2022

Volltextzugriff (PDF)

Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies

CNS drugs, 2021-07, Vol.35 (7), p.781-794

2021

Volltextzugriff (PDF)

Post hoc analyses of an open-label long-term study of esketamine nasal spray plus an oral antidepressant comparing results in older versus younger adults with treatment-resistant depression

The American journal of geriatric psychiatry, 2021-04, Vol.29 (4), p.S127-S128

2021

Volltextzugriff (PDF)

S114. Efficacy and Safety of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression

Biological psychiatry (1969), 2018-05, Vol.83 (9), p.S391-S391

2018

Volltextzugriff (PDF)

EFFICACY AND SAFETY OF ESKETAMINE NASAL SPRAY PLUS AN ORAL ANTIDEPRESSANT IN ELDERLY PATIENTS WITH TREATMENT-RESISTANT DEPRESSION

The American journal of geriatric psychiatry, 2019-03, Vol.27 (3), p.S180-S181

2019

Volltextzugriff (PDF)

POST HOC ANALYSES OF ESKETAMINE NASAL SPRAY PLUS AN ORAL ANTIDEPRESSANT IN ELDERLY PATIENTS WITH TREATMENT-RESISTANT DEPRESSION

The American journal of geriatric psychiatry, 2019-03, Vol.27 (3), p.S181-S182

2019

Volltextzugriff (PDF)

A randomized, multicenter, crossover psychometric evaluation study of an iPad-administered cognitive test battery in participants with major depressive disorder who responded to treatment with oral antidepressants

Journal of affective disorders, 2021-09, Vol.292, p.261-269

2021

Volltextzugriff (PDF)

1 – 13 von 13

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(13)

Sprache

Englisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(7)
Life Sciences & Biomedicine
(6)
Humans
(4)
Ketamine
(4)
Mental Depression
(4)
Psychiatry
(4)
Antidepressants
(3)
Antidepressive Agents - Administration & Dosage
(3)
Clinical Neurology
(3)
Double-Blind Method
(3)
Female
(3)
Ketamine - Administration & Dosage
(3)
Male
(3)
Middle Aged
(3)
Nasal Sprays
(3)
Neurosciences & Neurology
(3)
Treatment Outcome
(3)
Administration, Oral
(2)
Aged
(2)
Antidepressive Agents - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genome-wide association study and polygenic risk score analysis of esketamine treatment response

Risk Factors for Interstitial Cystitis in the General Population and in Individuals With Depression

Autism: Comorbidities and Treatment Patterns in the Real World, a Retrospective Cohort Study Among Children, Adolescents and Adults Newly Diagnosed with Autism

Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3

First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18

6.11 Clinician and Parent Reporting of Autism Spectrum Disorder Behaviors: Development of a Clinician Version of the Autism Behavior Inventory

Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study

Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies

Post hoc analyses of an open-label long-term study of esketamine nasal spray plus an oral antidepressant comparing results in older versus younger adults with treatment-resistant depression

S114. Efficacy and Safety of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression

EFFICACY AND SAFETY OF ESKETAMINE NASAL SPRAY PLUS AN ORAL ANTIDEPRESSANT IN ELDERLY PATIENTS WITH TREATMENT-RESISTANT DEPRESSION

POST HOC ANALYSES OF ESKETAMINE NASAL SPRAY PLUS AN ORAL ANTIDEPRESSANT IN ELDERLY PATIENTS WITH TREATMENT-RESISTANT DEPRESSION

A randomized, multicenter, crossover psychometric evaluation study of an iPad-administered cognitive test battery in participants with major depressive disorder who responded to treatment with oral antidepressants

Suchergebnisse filtern